People
Levi Lab Team
Moshe Levi, MD
Moshe Levi, MD, is Interim Dean for Research at Georgetown University Medical Center and is a professor in the Department of Biochemistry and Molecular & Cellular Biology.
Levi completed undergraduate training in chemical engineering at Northwestern University and received an MS in chemical engineering at Stanford University. He earned his MD from Albert Einstein College of Medicine and completed his internal medicine internship and residency at Cornell University and Memorial Sloan Kettering Hospital. He completed a nephrology clinical and research fellowship at the University of Colorado Health Sciences Center.
Bryce Jones
MD/PhD Candidate
Education: University of Notre Dame, BS in Chemistry, 2015; Georgetown University, MS in Pharmacology, 2016; Georgetown University School of Medicine MD/PhD (in progress)
Prior Research: Anticancer drug discovery in the organic chemistry lab of Dr. Marvin Miller at the University of Notre Dame. Synthesized and characterized anticancer compounds with nano-molar activity against breast cancer over the course of several iterations of a structure-activity relationship study. These compounds exhibited selective activity against breast cancer among the cell lines that were tested.
Article Submission: ERR agonism reverses mitochondrial dysfunction and inflammation in the aging kidney.
Kanchan Bhasin, MBBS, MS
Education: Bachelor of Medicine and Bachelor of Surgery (M.B.B.S.), Himalayan Institute of Medical Sciences , SRHU, India, 2017; M.S. Systems Medicine, Georgetown University, 2019
Position/Role in Levi Lab: Research Specialist
Primary focus is on conducting non-invasive imaging of human transplant and diabetic kidney biopsies using the novel Deep Imaging Via Emission Recovery (DIVER) microscope to perform Fluorescence Lifetime Imaging (FLIM) and Second Harmonic Generation (SHG).
Andrew Libby, PhD, MS
Postdoctoral Fellow of the American Heart Association
Education: Ph.D., 2018, Physiology, University of Colorado Anschutz Medical Center; M.S., 2010, Biochemistry, University of Colorado at Boulder; B.S., 2006, Chemistry, University of Tulsa
Position/Role in Levi Lab: Postdoctoral Fellow
Research: As a postdoctoral fellow of the American Heart Association, Dr. Libby's primary focus is studying the pathogenesis and treatment of diabetic kidney disease as well as renal disorders that arise from metabolic syndrome. Currently, Dr. Libby is examining the role of estrogen related receptors (ERRs) in the development of diabetic kidney disease, and is testing several compounds that have been developed to target ERRs as a method of attenuating the severity of this disorder. Additionally, he is involved in the development of improved mouse models of diabetic kidney disease by examining factors such as temperature, diet composition, etc. As a biochemist and physiologist, he uses a variety in vitro and in vivo techniques to study kidney disease including super-resolution microscopy (STED), single-cell RNA sequencing, the use of knockout/transgenic mouse models, pharmacology, and advanced cell culture methods.
